Skip to Main Content

Author Details

Howard H Yang
Center for Cancer Research, National Cancer Institute
2002
72
26
PMIDPaper TitleJournal TitlePublished Year
36799863Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer.Cancer Res2023
36973439Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway.Nat Cancer2023
37333132Melanoma clonal subline analysis uncovers heterogeneity-driven immunotherapy resistance mechanisms.bioRxiv2023
36799863Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer.Cancer Res2023
37491298SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma.Cell Biosci2023
37491298SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma.Cell Biosci2023
36973439Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway.Nat Cancer2023
37333132Melanoma clonal subline analysis uncovers heterogeneity-driven immunotherapy resistance mechanisms.bioRxiv2023
35042858Retinal pigment epithelium-specific CLIC4 mutant is a mouse model of dry age-related macular degeneration.Nat Commun2022
36291785<i>CSMD1</i> Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma.Cancers (Basel)2022
35939247Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems.Clin Exp Metastasis2022
35863434The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells.J Biol Chem2022
35727842Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence.PLoS Genet2022
35406404Modified eQTL and Somatic DNA Segment Alterations in Esophageal Squamous Cell Carcinoma for Genes Related to Immunity, DNA Repair, and Inflammation.Cancers (Basel)2022
35857355DNA Methyltransferase 3B-Mediated Intratumoral Heterogeneity and Therapeutic Targeting in Breast Cancer Recurrence and Metastasis.Mol Cancer Res2022
35042858Retinal pigment epithelium-specific CLIC4 mutant is a mouse model of dry age-related macular degeneration.Nat Commun2022
35406404Modified eQTL and Somatic DNA Segment Alterations in Esophageal Squamous Cell Carcinoma for Genes Related to Immunity, DNA Repair, and Inflammation.Cancers (Basel)2022
35727842Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence.PLoS Genet2022
35857355DNA Methyltransferase 3B-Mediated Intratumoral Heterogeneity and Therapeutic Targeting in Breast Cancer Recurrence and Metastasis.Mol Cancer Res2022
35939247Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems.Clin Exp Metastasis2022
35863434The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells.J Biol Chem2022
36291785<i>CSMD1</i> Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma.Cancers (Basel)2022
33945523CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.PLoS Genet2021
33958486Progesterone promotes immunomodulation and tumor development in the murine mammary gland.J Immunother Cancer2021
33945523CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.PLoS Genet2021
34083229Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis.Clin Cancer Res2021
34534377RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).Mol Carcinog2021
34534377RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).Mol Carcinog2021
33958486Progesterone promotes immunomodulation and tumor development in the murine mammary gland.J Immunother Cancer2021
34083229Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis.Clin Cancer Res2021
31582516The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models <i>In Vivo</i> Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ.Clin Cancer Res2020
32375686Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.BMC Cancer2020
32265227Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.Cancer Res2020
32265226Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.Cancer Res2020
31582516The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models <i>In Vivo</i> Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ.Clin Cancer Res2020
31949145Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.Nat Commun2020
32053966Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer.Cancers (Basel)2020
32284588Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy.Nat Med2020
32463822The genomic landscape of metastasis in treatment-naïve breast cancer models.PLoS Genet2020
32880016Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.Breast Cancer Res Treat2020
32513899Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures.Mol Cancer Res2020
32943547Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma.Mol Cancer Ther2020
32053966Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer.Cancers (Basel)2020
31949145Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.Nat Commun2020
32943547Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma.Mol Cancer Ther2020
32880016Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.Breast Cancer Res Treat2020
32284588Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy.Nat Med2020
32463822The genomic landscape of metastasis in treatment-naïve breast cancer models.PLoS Genet2020
32375686Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.BMC Cancer2020
32265227Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.Cancer Res2020
  • 1 - 50 of 144

Recommended Authors

University of Science and Technology Liaoning
Career Start Year 2009
Number of shared co-authors 1
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 8
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 1
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 5
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 2
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 8
MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 6
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 2
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 5
University of Helsinki
Career Start Year 2002
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 6
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 6
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
University of Oslo
Career Start Year 1997
Number of shared co-authors 0
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 1
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 4
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
University of South Carolina
Career Start Year 1993
Number of shared co-authors 2
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 10
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 0
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 10

Collaborators

National Cancer Institute, National Institutes of Health
Co-authored papers 66
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
The University of Manchester
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 3
National Cancer Institute, Frederick National Laboratory for Cancer Research
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Robert Wood Johnson Medical School, The State University of New Jersey
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 2
National Cancer Institute.
Co-authored papers 2
St Jude Children's Research Hospital
Co-authored papers 2
University of California San Diego Health
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
The Francis Crick Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Co-authored papers 1
The Usher Institute, The University of Edinburgh
Co-authored papers 1
Peking University Third Hospital
Co-authored papers 1
University of Illinois at Urbana-Champaign
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1